Methadone but not Morphine Inhibits Lubiprostone-Stimulated Cl- Currents in T84 Intestinal Cells and Recombinant Human ClC-2, but not CFTR Cl- Currents

Cell Biochemistry and Biophysics

Volumn 66, Issue 1, 2013, Pages 53-63

  Cuppoletti, John ^a   Chakrabarti, Jayati ^a   Tewari, Kirti ^a   Malinowska, Danuta H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Lubiprostone; Methadone; Morphine; Prostone; T84 cells

Indexed keywords

EID: 84876176277     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9406-6     Document Type: Article

References (39)

1. Cryer, B., Katz, S., Vallejo, C., Scott, C., Joswick, TR., Dolecek, G. (2010). A phase 3, randomized, double-blind, placebo-controlled clinical trial of lubiprostone for the treatment of opioid-induced bowel dysfunction in patients with chronic, non-cancer pain. Gastroenterology, 138, S-129 [abst 906].
2. Jamal, M. M., Mareya, S. M., Woldegeorgis, F., Joswick, T. R., & Ueno, R. (2012). Lubiprostone significantly improves treatment response in non-methadone opioid-induced bowel dysfunction patients with chronic, non-cancer pain: results from a Phase 3, randomized, double-blind, placebo-controlled clinical trial. Gastroenterology, 142, S144-S145. [abst 848a].
3. Wong, B. S., & Camilleri, M. (2011). Lubiprostone for the treatment of opioid-induced bowel dysfunction. Expert Opinion on Pharmacotherapy, 12, 983-990.
4. Cuppoletti, J., Malinowska, D. H., Tewari, K. P., Li, Q. J., Sherry, A. M., Patchen, M. L., et al. (2004). SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. American Journal of Physiology. Cell Physiology, 287, C1173-C1183.
5. - secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. Gastroenterology, 137, 976-985.
6. - secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84. Digestive Diseases and Sciences, 56, 339-351.
7. -currents in T84 cells. San Diego: DDW.
8. Bao, H. F., Liu, L., Self, J., Duke, B. J., Ueno, R., & Eaton, D. C. (2008). A synthetic prostone activates apical chloride channels in A6 epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology, 295, G234-G251.
9. Tewari, K. P., Malinowska, D. H., Sherry, A. M., & Cuppoletti, J. (2000). PKA and arachidonic acid activation of human recombinant ClC-2 chloride channels. American Journal of Physiology. Cell Physiology, 279, C40-C50.
10. - channel. Journal of Biological Chemistry, 279, 21849-21856.
11. Allescher, H. D., Ahmad, S., Kostka, P., Kwan, C. Y., & Daniel, E. E. (1989). Distribution of opioid receptors in canine small intestine: implications for function. American Journal of Physiology. Gastrointestinal and Liver Physiology, 256, G966-G974.
12. Bagnol, D., Mansour, A., Akil, H., & Watson, S. J. (1997). Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract. Neuroscience, 81, 579-591.
13. Yang, J. C., Shan, J., Ng, K. F., & Pang, P. (2000). Morphine and methadone have different effects on calcium channel currents in neuroblastoma cells. Brain Research, 870, 199-203.
14. Ulens, C., Daenens, P., & Tytgat, J. (1999). The dual modulation of GIRK1/GIRK2 channels by opioid receptor ligands. European Journal of Pharmacology, 385, 239-245.
15. + current in squid giant fiber lobe neurons. Journal of General Physiology, 107, 243-260.
16. + currents. Journal of Pharmacology and Experimental Therapeutics, 303, 688-949.
17. Eap, C. B., Crettol, S., Rougier, J. S., Schläpfer, J., Sintra Grilo, L., Déglon, J. J., et al. (2007). Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clinical Pharmacology and Therapeutics, 81, 719-728.
18. Garcia-Olivares, J., Alekov, A., Boroumand, M. R., Begemann, B., Hidalgo, P., & Fahlke, C. (2008). Gating of human ClC-2 chloride channels and regulation by carboxy-terminal domains. Journal of Physiology, 586, 5325-5336.
19. Schwiebert, E. M., Cid-Soto, L. P., Stafford, D., Carter, M., Blaisdell, C. J., Zeitlin, P. L., et al. (1998). Analysis of ClC-2 channels as an alternative pathway for chloride conduction in cystic fibrosis airway cells. Proceedings of the National Academy of Sciences of the United States of America, 95, 3879-3884.
20. Makara, J. K., Rappert, A., Matthias, K., Steinhäuser, C., Spät, A., & Kettenmann, H. (2003). Astrocytes from mouse brain slices express ClC-2-mediated Cl- currents regulated during development and after injury. Molecular and Cellular Neuroscience, 23, 521-530.
21. Zúñiga, L., Niemeyer, M. I., Varela, D., Catalán, M., Cid, L. P., & Sepúlveda, F. V. (2004). The voltage-dependent ClC-2 chloride channel has a dual gating mechanism. Journal of Physiology, 555, 671-682.
22. Geisse, S., Jordan, M., & Wurm, F. M. (2005). Large-scale transient expression of therapeutic proteins in mammalian cells. Methods in Molecular Biology, 308, 87-98.
23. Geisse, S., Orakci, O., Pabler, A., Patoux, A., Rinaldi, D., Watkins, J., et al. (1999). Float!-and express more: converting the HEK. EBNA/oriP system to suspension culture. In A. Bernard, et al. (Eds.), Animal cell technology: Products from cells, cells as products (pp. 339-345). Dordrecht: Kluwer Academic Publishers.
24. Geisse, S., & Henke, M. (2005). Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production. Journal of Structural and Functional Genomics, 6, 165-170.
25. Zhang, Z.-S., Tranquillo, J., Neplioueva, V., Bursac, N., & Grant, A. O. (2007). Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease. American Journal of Physiology. Heart and Circulatory Physiology, 292, H399-H407.
26. Tuvesson, O., Uhe, C., Rozkov, A., & Lullau, E. (2008). Development of a generic transient transfection process at 100 l Scale. Cytotech, 56, 123-136.
27. Geisse, S. (2009). Reflections on more than 10 years of TGE approaches. Protein Expression and Purification, 64, 99-107.
28. + channel. American Journal of Physiology, 271, L775-L784.
29. 2+ store in A7r5 and 16HBE14o- cells. Journal of Biological Chemistry, 277, 6898-6902.
30. - secretion. American Journal of Physiology, 272, C976-C988.
31. 16-mediated stimulation of phospholipase C. Journal of Neurochemistry, 70, 2203-2211.
32. Gaginella, T. S., Rimele, T. J., & Wietecha, M. (1983). Studies on rat intestinal epithelial cell receptors for serotonin and opiates. Journal of Physiology, 335, 101-111.
33. Nylund, G., Pettersson, A., Bengtsson, C., Khorram-Manesh, A., Nordgren, S., & Delbro, D. S. (2008). Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Digestive Diseases and Sciences, 53, 461-466.
34. Raynor, K., Kong, H., Mestek, A., Bye, L. S., Tian, M., Liu, J., et al. (1995). Characterization of the cloned human mu opioid receptor. Journal of Pharmacology and Experimental Therapeutics, 272, 423-428.
35. Knapp, R. J., Malatynska, E., Collins, N., Fang, L., Wang, J. Y., Hruby, V. J., et al. (1995). Molecular biology and pharmacology of cloned opioid receptors. The FASEB Journal, 9, 516-525.
36. Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J., et al. (2002). Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. The Journal of Clinical Investigation, 110, 1651-1658.
37. Gharagozlou, P., Demirci, H., David Clark, J., & Lameh, J. (2003). Activity of opioid ligands in cells expressing cloned mu opioid receptors. BMC Pharmacology, 3, 1-8.
38. Onoprishvili, I., Andria, M. L., Vilim, F. S., Hiller, J. M., & Simon, E. J. (1999). The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells. Brain Research. Molecular Brain Research, 73, 129-137.
39. Arden, J. R., Segredo, V., Wang, Z., Lameh, J., & Sadée, W. (1995). Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. Journal of Neurochemistry, 65, 1636-1645.